Uncategorized
Ocular Therapeutix™ to Present at Three Upcoming Investor Conferences
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Antony Mattessich, Chief Executive Officer, will present at three upcoming investor conferences in September: Morgan Stanley 15th Annual Global Healthcare ConferenceFireside Chat: Monday, September 11, 2017 at 1:05 p.m. Eastern TimeGrand Hyatt New